Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVRx, Inc. Director's Dealing 2021

Jun 30, 2021

33690_dirs_2021-06-29_cbe3a64c-7dcd-4ce0-ae0f-bd5fa36a7be9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CVRx, Inc. (CVRX)
CIK: 0001235912
Period of Report: 2021-06-29

Reporting Person: BRINTNALL JOHN (Chief Strategy Officer and Sec)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4945 Indirect
Common Stock 4681 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series F-2 Preferred Stock $ Common Stock (2242) Direct
Series G Preferred Stock $ Common Stock (5658) Direct
Stock Option $0.237 2025-08-06 Common Stock (1896) Direct
Stock Option $0.237 2025-08-06 Common Stock (2275) Direct
Stock Option $0.237 2025-08-06 Common Stock (3792) Direct
Stock Option $0.237 2025-08-06 Common Stock (3286) Direct
Stock Option $0.237 2023-11-11 Common Stock (4771) Direct
Stock Option $0.237 2024-09-10 Common Stock (3792) Direct
Stock Option $0.237 2025-06-30 Common Stock (1264) Direct
Stock Option $0.237 2026-09-27 Common Stock (9735) Direct
Stock Option $0.237 2028-02-15 Common Stock (21745) Direct
Stock Option $0.237 2028-02-15 Common Stock (23767) Direct
Stock Option $3.955 2029-07-23 Common Stock (34134) Direct
Stock Option $4.35 2030-09-30 Common Stock (14506) Direct
Stock Option $4.35 2030-09-30 Common Stock (14304) Direct
Stock Option $4.35 2030-09-30 Common Stock (13006) Direct
Stock Option $4.35 2030-09-30 Common Stock (12885) Direct
Stock Option $7.119 2031-02-03 Common Stock (18963) Direct

Footnotes

F1: Each share of preferred stock is convertible, at the option of the holder, into shares of common stock at the then-effective conversion ratio for no additional consideration and has no expiration date. The shares of preferred stock will automatically convert into shares of common stock at the then-appliable conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares) upon the closing of the Issuer's initial public offering. The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the common stock.

F2: Shares of Series F-2 Convertible Preferred Stock are convertible into shares of common stock at a rate of 1-for-0.025857287.

F3: Shares of Series G Convertible Preferred Stock are convertible into shares of common stock at a rate of 1-for-0.0632143218.

F4: Fully exercisable.

F5: Fully exercisable, subject to Issuer's right to repurchase shares at the exercise price, which repurchase right lapsed with respect to 25% of the shares on February 26, 2019 and lapses with respect to the 1/48th of the shares each month thereafter.

F6: Vested as to 25% of the shares on January 28, 2020 and vests as to 1/48th of the shares on the 15th of each month thereafter.

F7: Vested as to 25% of the shares on July 24, 2020 and vests as to 1/48th of the shares each month thereafter.

F8: Vests as to 75% of the shares on October 1, 2020 and as to 1/48th of the shares each month thereafter.

F9: Vests as to 25% of the shares on October 1, 2020 and as to 1/48th of the shares each month thereafter.

F10: Vests as to 25% of the shares on October 1, 2021 and as to 1/48th of the shares each month thereafter.

F11: Vests as to 25% of the shares on February 4, 2022 and as to 1/48th of the shares each month thereafter.